“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Monday, August 11, 2025

Nosebleed


Introduction
Nosebleed, medically termed epistaxis, is bleeding from the nasal cavity due to rupture of blood vessels within the nasal mucosa. It is a common condition that can range from mild and self-limiting to severe and life-threatening. Most cases are anterior in origin and benign, but posterior bleeds may require urgent medical intervention.


Epidemiology

  • Common in all age groups, with peaks in children (2–10 years) and older adults (>60 years).

  • Anterior bleeds account for ~90% of cases (Kiesselbach’s plexus).

  • Posterior bleeds are less common but often more severe and associated with comorbidities such as hypertension and atherosclerosis.


Etiology

Local causes

  • Trauma (nose picking, facial injury, nasal surgery).

  • Dry air or low humidity leading to mucosal crusting and vessel fragility.

  • Nasal inflammation (rhinitis, sinusitis).

  • Nasal tumors or polyps.

  • Foreign bodies in the nose.

Systemic causes

  • Hypertension.

  • Coagulopathies (e.g., hemophilia, thrombocytopenia).

  • Liver disease.

  • Medications (anticoagulants such as warfarin, direct oral anticoagulants, antiplatelets like aspirin or clopidogrel, intranasal corticosteroids).


Pathophysiology
Nasal mucosa has a rich vascular supply from both internal and external carotid arteries.

  • Anterior epistaxis: Most commonly arises from Kiesselbach’s plexus (Little’s area) – a confluence of vessels in the anterior nasal septum.

  • Posterior epistaxis: Originates from branches of the sphenopalatine artery, deeper and harder to control.


Clinical Presentation

  • Unilateral or bilateral bleeding from nostrils.

  • May present with blood in the throat (posterior bleed).

  • Associated symptoms: dizziness, lightheadedness, syncope in severe cases.

  • Signs of hypovolemia may be present in massive bleeding.


Diagnosis

History

  • Onset, duration, frequency of episodes.

  • Precipitating factors (trauma, sneezing, medications).

  • Past history of nasal or systemic disease.

  • Drug history (especially anticoagulants).

Examination

  • Vital signs (to assess stability).

  • Inspection of nasal cavity with nasal speculum.

  • Identify bleeding site if possible.

  • Examine for signs of systemic disease (bruising, petechiae).

Investigations

  • Usually not required for single mild episodes.

  • CBC, coagulation profile, renal and liver function tests for recurrent/severe bleeds.

  • Nasal endoscopy if bleeding source is not identified.


Management

First aid measures (for mild anterior epistaxis)

  • Sit upright, lean forward to avoid aspiration.

  • Pinch soft part of nose (below nasal bone) for 10–15 minutes continuously.

  • Apply cold compress to bridge of nose to promote vasoconstriction.

  • Avoid lying flat or tilting head back.


Medical and procedural treatment

1. Topical Vasoconstrictors (for active anterior bleeds)

  • Oxymetazoline 0.05% nasal spray: 2–3 sprays in affected nostril, may repeat after 10 minutes if needed.

  • Phenylephrine 0.25–0.5% nasal drops: 2–3 drops, up to every 4 hours.

2. Chemical or Electrical Cautery

  • Silver nitrate sticks applied to bleeding point after topical anesthesia (lidocaine 4%).

  • Avoid bilateral septal cautery at same session to prevent perforation.

3. Nasal Packing

  • Anterior nasal packing: Ribbon gauze soaked in petroleum jelly or antibiotic ointment; or use prefabricated nasal tampons.

  • Posterior nasal packing: Balloon catheters (e.g., Foley catheter) or commercial posterior packs; requires monitoring for hypoxia.

4. Systemic Medications (adjunctive)

  • Tranexamic acid: 500–1000 mg orally every 8 hours for short-term use, or topical tranexamic acid solution applied to nasal mucosa.

  • Antibiotics (e.g., amoxicillin–clavulanate 625 mg orally every 8 hours) may be given with nasal packing to prevent sinusitis or toxic shock syndrome.


Surgical interventions (for refractory bleeding)

  • Endoscopic ligation of sphenopalatine artery.

  • Arterial embolization (interventional radiology).


Prevention of recurrence

  • Keep nasal mucosa moist with saline sprays or petroleum jelly.

  • Use humidifiers in dry environments.

  • Avoid nasal trauma and vigorous nose blowing.

  • Manage underlying conditions (hypertension, coagulopathy).


Complications

  • Aspiration of blood leading to airway compromise.

  • Anemia from chronic/recurrent bleeding.

  • Septal perforation (if cautery or packing is excessive).

  • Infection following nasal packing.




No comments:

Post a Comment